Home › Enlarged Prostate (BPH) › New York › New Rochelle
Enlarged Prostate (BPH) clinical trials in New Rochelle, NY
4 studies for Enlarged Prostate (BPH) are looking for participants at sites in and around New Rochelle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Post-Market Study to Assess iTind Safety in Comparison to UroLift
Recruiting
- Feinstein Institutes for Medical Research / Northwell Health, Syosset · 16 mi away
Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.
RecruitingHealthy volunteers welcome
- Northwell Health, Syosset · 16 mi away
Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry
RecruitingObservational study
- The Smith Institute of Urology/Northwell Health, Syosset · 16 mi away
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
Recruiting
- Northwell Health, Syosset · 16 mi away
About Enlarged Prostate (BPH)
Enlarged prostate, or benign prostatic hyperplasia (BPH), is a common problem in men over 50. Learn about the symptoms and treatments.
More about Enlarged Prostate (BPH) on MedlinePlus
Enlarged Prostate (BPH) trials in other cities
- Austin, TX4 studies
- Houston, TX3 studies
- Las Vegas, NV3 studies
- Cleveland, OH3 studies
- Chicago, IL3 studies
- San Francisco, CA3 studies
- Evanston, IL3 studies
Other studies in New Rochelle
- Breast Cancer38 studies
- Non-Small Cell Lung Cancer18 studies
- Prostate Cancer16 studies
- Multiple Myeloma14 studies
- Acute Myeloid Leukemia13 studies
- Bladder Cancer11 studies
- Lung Cancer11 studies
- Endometrial Cancer11 studies
- Metastatic Cancer10 studies
- Cancer (all types)10 studies
- Ovarian Cancer9 studies
- Cardiovascular Disease8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.